Antimicrobial therapy can increase the colonization density of gastrointestinal vancomycin-resistant enterococci (VRE). Among previously VRE-colonized patients, we evaluated VRE colonization before and after initiation of antimicrobial therapy by means of polymerase chain reaction (PCR) and culture. Perianal swab samples were obtained at admission to the hospital and after receipt of antimicrobial therapy. At admission, 12 (21%) of 56 patients were culture positive, and 17 (30%) had vanA or vanB genes detected by PCR. Culture results showed that 25 (86%) of 29 culture-negative patients from whom a second swab sample was obtained remained culture negative, 2 (6.9%) had a relapse of colonization with a strain related to the previously colonizing strain type (2 and 6 days after admission), and 2 (6.9%) tested positive for a previously undetected strain type (16 and 19 days after admission). PCR at admission detected VRE in 1 of the 2 patients who later relapsed. Patients with negative results of culture of the initial swab sample and of PCR were unlikely to relapse after receipt of antimicrobial therapy.
patient transmission of VRE, which relies on identification of VRE-colonized patients and subsequent implementation of control measures [4] [5] [6] [7] . Although screening patients to detect VRE colonization may be cost-effective [8] , one barrier to initiating an aggressive screening strategy is the cost of implementing contact isolation precautions. Because VRE colonization can persist for a long duration [9] , aggressive screening strategies to detect VRE colonization may result in a large and increasing number of patients who require contact isolation precautions. To cease contact isolation precautions for a patient, some infection-control programs have adopted a strategy that requires 3 negative results of surveillance cultures separated in time by at least 1 week [10] . Such a strategy is logistically complicated, and, for some patients, likely results in unnecessary continuation of contact isolation precautions. For example, serial cultures must be performed, and Downloaded from https://academic.oup.com/cid/article-abstract/38/6/780/319326 by guest on 14 February 2019 good record-keeping must be maintained. A sensitive and rapid method for VRE detection, such as PCR [11, 12] , may be able to identify those previously VRE-colonized patients who are at low risk for relapse during their hospital stay. Identifying these patients would reduce the duration of contact isolation.
To determine how often previously VRE-colonized patients relapse after receipt of antimicrobial therapy, we evaluated the gastrointestinal VRE-colonization status of previously VREpositive patients at admission to the hospital and after receipt of antimicrobial therapy. To detect VRE, we performed PCR and culture on selective media.
PATIENTS AND METHODS

Study design.
We performed a prospective cohort study during 2 separate periods, June-November 2000 and July-October 2001. We offered study enrollment to patients 117 years of age who were known to have been either colonized or infected with VRE during a previous hospitalization and who were being readmitted to Northwestern Memorial Hospital (Chicago, IL). We excluded patients who had received 124 h of antimicrobial therapy before swab samples were obtained. Rectal and perianal swab samples were obtained from consenting patients; only perianal swab samples were obtained from neutropenic or thrombocytopenic patients.
We obtained follow-up swab samples from patients who received antimicrobial therapy for 148 h during the enrollment hospitalization or a subsequent hospitalization that occurred р60 days after the previous discharge. We performed a maximum of 3 sampling episodes, 1 at the time of enrollment and 2 after receipt of antimicrobial therapy. The following data were collected by medical record review and from microbiology records: age, sex, race, acid suppression therapy, underlying diagnosis, reason for admission, hospitalization within the previous 3 months, antimicrobial therapy from 3 months before admission until the time the last swab sample was obtained, steroid therapy, neutropenia, total parenteral nutrition therapy, dates on which the most recent prestudy VRE-positive culture and the last VRE-negative stool specimen were obtained, and previous VRE isolate genotypes (vanA or vanB) and strain types.
We evaluated conversion from VRE negativity to VRE positivity using both culture and PCR. Because perianal swab samples were more commonly obtained than were rectal swab samples, and because we found good agreement between analyses of perianal and rectal specimens ( ), we restricted our k p 0.78 analyses to perianal swabs.
Informed consent was obtained from patients or their guardians. US Department of Health and Human Services and Northwestern Memorial Hospital guidelines on human experimentation were followed in the conduct of the clinical research.
Microbiological methods. Samples were obtained with a rayon-tipped swab and were processed within 4 h of collection. Fecal material from the swabs was suspended in 350 mL of sterile water and vortexed for 5 s. Two 50-mL aliquots were removed; one was placed in a sterile tube for DNA extraction, and the other was inoculated directly onto an Enterococcosel plate (BBL; Becton Dickinson) containing 6 mg/mL of vancomycin. Isolates were identified as Enterococcus faecium or Enterococcus faecalis by standard biochemical methods [13] . Agar dilution susceptibility testing was performed according to NCCLS recommendations [14] . The samples were processed using the MasterPure DNA Purification Kit protocol (Epicentre Technologies), with slight modifications [12] . Oligonucleotide primers for the vanA and vanB genes were used in multiplex PCR [15] . Purified DNA from swab samples (5 mL) was added to a 50-mL hot-start reaction mixture prepared using the Platinum PCR SuperMix (Invitrogen) or AmpliTaq Gold PCR MasterMix (Applied Biosystems) and containing 0.4 mmol/L of each primer. The PCR products-732 bp for vanA and 635 bp for vanB-were resolved on a 1.5% agarose gel, stained with Sybr Green (Molecular Probes), and visualized under UV light.
Strain typing was performed by restriction endonuclease analysis. Total genomic DNA was isolated from VRE isolates with the MasterPure DNA purification kit and digested with HindIII (Invitrogen). The DNA banding patterns were visually compared with one another to determine whether the isolates were genetically related (190% similar pattern) or unrelated (distinct patterns) [16] .
Statistical methods. Patient data and laboratory results were entered into a database and linked by medical record number. A course of antimicrobial treatment was defined as continuous therapy without interruption, unless it was dose adjusted for those patients with renal insufficiency. An antimicrobial day was defined as either any unique day in which 1 antimicrobial agent was received or as any unique antimicrobial agent that was received. For example, levofloxacin and vancomycin provided on a single day would be equal to 2 antimicrobial days. No statistical test results are displayed for analyses of antimicrobial receipt, because of the small number of case patients.
Data were analyzed using EpiInfo software, version 6.03 (CDC) [17] , or SAS, version 8.0 for personal computers (SAS Institute). Categorical variables were compared using Fisher's exact test or x 2 analysis. Relative risks and 95% CIs were calculated. A kappa correlation coefficient (k) was calculated for simultaneously obtained perianal and rectal swab samples.
RESULTS
Patient characteristics.
Of the 58 patients who consented to provide swab samples at admission, perianal swab samples were obtained from 56; 2 patients had a colostomy and did not undergo perianal swabbing. Of these 56 patients, 29 (52%) were men, 35 (63%) were white, 40 (71%) had been hospitalized within 30 days before admission, 4 (7%) were neutropenic, and the median age was 54 years (range, 21-90 years). The most common primary underlying diagnoses were receipt of a solid organ transplant (11 patients), nonhematologic malignancy (8), paraplegia (8) , hematologic malignancy (6), or receipt of a hematopoietic stem cell transplant (4). Prior to study enrollment, VRE was yielded most commonly in cultures of the following specimens: rectal swabs or stool (39 samples), urine (8) , and wounds (6) . Cultures performed before study entry yielded E. faecium alone in 47 cases and E. faecalis alone in 6, both E. faecium and E. faecalis in 2, and an unknown organism in 1. Analysis of swab samples obtained at admission. Cultures of swab samples obtained from 12 (21%) of the 56 patients at admission were positive; both E. faecium (10 isolates) and E. faecalis (2 isolates) were detected. Of the 12 isolates, 10 had vanA and 2 had vanB phenotypes. Eleven of these 12 patients had an isolate obtained before enrollment that was available for strain typing; for 7 (64%), the strain types recovered from swab samples obtained before study entry were related to those obtained during the enrollment admission. The interval between the most recent prestudy VRE-positive culture and the time at which the admission swab sample was obtained was shorter for culture-positive patients than for culture-negative patients; other characteristics were similar for the 2 groups (table 1) .
PCR analyses of swab samples obtained from 17 (30%) of 56 patients at admission were positive; vanA (14 isolates), vanB (2), or both (1) genotypes were detected. Compared with PCR-negative patients, PCR-positive patients were more likely to have recently been hospitalized, to have previously been colonized by E. faecalis, or to have had a shorter duration of time between the most recent prestudy VRE-positive culture and the time at which the admission swab sample was obtained (table 2) .
Analysis of swab samples obtained after receipt of antimicrobial therapy. Of the 56 patients who provided a swab specimen at admission to the hospital, 36 provided a second swab specimen у48 h after receipt of antimicrobial therapy. Of these 36 patients, 29 (81%) had a culture of an initial swab sample that did not yield VRE. The median number of antimicrobial therapy days between the times at which the first and final swab samples were obtained was 12 (interquartile range, 5-18).
Culture results revealed that all 7 patients who had VRE detected at admission also had VRE detected on subsequent swab cultures, and most patients who were culture negative at admission had subsequent swab cultures that were negative for VRE (figure 1). Of the 4 patients who converted from culture negative to culture positive, only 2 relapsed with a strain type related to the strain type isolated in a culture that was performed before study entry; 1 of these 2 patients was PCR positive at admission (table 3) . The interval between the times at which initial and follow-up swab samples were obtained and the duration of antimicrobial therapy were greater for those patients from whom an unrelated strain type was recovered than for the 2 patients who relapsed (table 3) .
To determine whether PCR at admission would better predict persistence of undetectable VRE in culture, we compared patients' VRE colonization status at admission, as determined by PCR, to their VRE colonization status after antimicrobial receipt, as determined by culture. Of the 26 patients who were PCR negative at admission, culture results for only 1 patient (3.8%) were positive for the previous strain type after anti- microbial receipt, and 2 patients (7.7%) acquired an unrelated strain type (figure 1). Among the 3 patients who were PCR positive and culture negative for VRE at admission, a followup culture of perianal swab specimen obtained from 1 was positive for VRE; culture of perianal swab sample obtained from 1 patient was negative for VRE, but results of culture of 2 subsequent rectal swab specimens were positive (data not included in tables or in figure 1) ; and results of culture and PCR of subsequent swab samples remained negative for 1 patient. For the first 2 of these 3 patients, PCR of follow-up swab samples remained positive for VRE. The number and types of antimicrobial courses prescribed for patients who were culture negative at admission and data on their conversion to culture positivity during hospitalization are displayed in table 4.
DISCUSSION
Receipt of certain antimicrobial agents can unmask the presence of gastrointestinal VRE colonization by increasing the density of VRE colonization [18] , which may then exceed the threshold of detection. We studied a group of patients at risk for either VRE acquisition or relapse of previous VRE colonization (i.e., patients who received antimicrobial therapy during their hospital stay) [19] . Among these patients, we found that relapse (i.e., colonization with a related strain type) was uncommon. Of the 4 patients who became VRE positive, 2 had acquired an unrelated strain type, and both acquisitions occurred 12 weeks after the initial swab specimen was obtained. For 1 of the 2 patients who relapsed, PCR of the initial swab specimen detected VRE. In 2 previous studies that included patients in long-term care facilities who had cleared VRE, 24% of patients for whom cultures were performed over a 5-week period [9] , and 62% of patients for whom cultures were performed over a mean period of 6 months had VRE detected by means of broth enrichment [20] . However, in both studies, the majority of patients in whom VRE was detected after having cleared VRE had acquired an isolate unrelated to the initial isolate. We evaluated only patients in acute-care facilities, who, on average, have shorter lengths of stay than do patients in long-term care facilities, which thus limited our ability to observe patients for long periods of time. However, our study may be more relevant to decisions about continued use of isolation precautions in acute-care facilities.
We also found that the longer the interval between the most recent VRE-positive culture and the time at which the admission swab specimen was obtained, the less likely it was for us to detect VRE colonization. Other investigators have reported that continued VRE colonization is inversely associated with the interval between discontinuation of antimicrobial therapy and performance of a second culture [18] . Comparisons between studies to determine persistence of VRE carriage are complicated by several factors, including availability of isolates for strain typing, number of cultures evaluated, laboratory method used for detection (e.g., PCR or broth enrichment), and patient selection (e.g., patients available for follow-up may only include those patients who remain in the health care facility or who require repeat visits to health care facilities).
In addition to antimicrobial receipt and time of acquisition, other factors may predispose patients to relapse (i.e., increased density of VRE colonization above the threshold of detection, repeat acquisition of a similar strain type, or acquisition of unrelated strain types). These additional factors include the colonization pressure during the patient's admission, underlying diseases, duration of hospitalization, previous exposure to health care facilities, or hospitalization in the intensive care unit [21] [22] [23] . Our study did not have sufficient numbers of patients who either relapsed with a related strain type or acquired an unrelated strain type to evaluate these other factors. We did detect acquisition of unrelated VRE strains from 2 Figure 1 . Flow diagram of results of laboratory tests for detection of vancomycin-resistant enterococci (VRE) in patients from whom samples were obtained for culture at admission and after 12 days of antimicrobial therapy at Northwestern Memorial Hospital (Chicago). Results of analysis of initial swab specimens are shown for both culture (A) and PCR (B), as well as the follow-up culture results. *Two patients acquired a new strain type, and 2 patients relapsed with a related strain type. For 1 of the 2 patients who relapsed, PCR of the initial swab specimen was positive for VRE. †Initial cultures of specimens obtained from these patients were negative for VRE. ‡The genotype detected was concordant with that of the previous VRE phenotype for 1 patient (i.e., vanA/vanA) and was discordant for 2 patients (i.e., vanA/vanB). patients, 1 who had been in the hospital for 16 days and 1 who had been hospitalized twice for a total of 7 hospital days. Therefore, it may be important to repeat screening on patients who have prolonged hospital stays or frequent admissions to the hospital. Compared with culture on selective media, PCR provides more rapid results-potentially on the day of specimen acquisition-and PCR is a sensitive method to detect gastrointestinal colonization with vanA VRE [12, 24] . Many facilities do not remove a previously VRE-colonized patient from contact isolation precautions until the patient has 3 VRE-negative stool cultures separated in time by 1 week. This strategy is supported by studies demonstrating that a single culture that uses selective media can be insensitive for VRE detection [25, 26] and that VRE colonization may recur, especially after antimicrobial receipt [18] . However, these studies did not evaluate the use of PCR, which can be more sensitive than culture on selective media [12] . A possible explanation for detection of vanA or vanB genetic elements by PCR of culture-negative swab specimens-other than that PCR has a lower threshold of detection-is that PCR may detect genes from nonviable VRE isolates or from nonenterococcal organisms [27] . Other investigators have reported that rectal swab cultures have poor sensitivity at low fecal densities of VRE [25, 26] and that PCR of rectal swab specimens is a sensitive method for VRE detection [11] . In our study, stool cultures were not evaluated, and it is possible that PCR-positive, culture-negative patients have low fecal densities of VRE. Because low fecal densities of VRE decrease the efficiency of environmental contamination [26] , the importance of PCR detection of VRE from culture-negative patients is unknown. However, the density of VRE in an individual is variable and dependent on recent antimicrobial exposure [18, 26] .
We studied a population that routinely would receive isolation precautions at the study facility. Because PCR-positive, culture-negative laboratory results may represent VRE colonization, a conservative strategy would be to continue contact isolation precautions until the patient has subsequent swab samples that are culture negative for VRE [10] .
Our study may not be generalizable to facilities with high rates of extended-spectrum cephalosporin use. In our study, extended-spectrum cephalosporin therapy was uncommon, which may have contributed to infrequent conversion from VRE negativity to VRE positivity. However, vancomycin was administered to 35% of the patients in our study, and vancomycin receipt likely contributes to persistence of carriage [18, 19] . Also, in long-term care facilities, such as nursing homes or rehabilitation facilities, rapid assessment of VRE colonization status may not be important. In addition, use of PCR requires either an on-site microbiologist who can perform the test or a laboratory that can process the swab specimens in a timely manner. Because we performed these tests in a research setting, which allowed rapid delivery of specimens to a laboratory that had experienced personnel, our results need to be replicated in a routine clinical setting. The majority of isolates recovered from our study patients had the vanA phenotype, and the ability of PCR to detect isolates with the vanB gene has been less well studied. Finally, some patients may have remained colonized with VRE is sites outside of the gastrointestinal tract, such as urine, sputum, or wounds, and we did not collect specimens from nongastrointestinal sites.
As health care facilities try to control the emergence of antimicrobial-resistant organisms, strategies that minimize cost with no or little diminution in the effectiveness of the clinical intervention are increasingly important. Our findings suggest that PCR can be used to identify previously colonized patients at low risk for relapse during their hospital stay, potentially reducing the number of unnecessary days of contact isolation precautions.
